Introduction to IRB Continuing Review
The Institutional Review Board (IRB) plays a crucial role in ensuring the protection of human subjects involved in research studies. Once a study is approved, it is not the end of the IRB's involvement. In fact, the IRB is required to conduct continuing reviews of approved and ongoing studies to ensure that they continue to meet the regulatory requirements and that the rights and welfare of the participants are protected.
The frequency and scope of these continuing reviews vary depending on the study's risk level, the number of participants, and the study's complexity. The IRB may require more frequent reviews for studies that pose higher risks to participants or for studies that involve vulnerable populations, such as children or prisoners.
Purpose of IRB Continuing Review
The primary purpose of the IRB continuing review is to ensure that the study is being conducted in accordance with the approved protocol, that the risks to participants are minimized, and that the benefits of the study continue to outweigh the risks. The IRB also reviews any changes to the study protocol, including changes to the informed consent document, to ensure that they are consistent with the original approval.
During the continuing review, the IRB also assesses the study's progress, including the number of participants enrolled, the data collected, and any adverse events or unanticipated problems that have occurred. This information helps the IRB to determine whether the study should continue as approved or if modifications are needed to ensure participant safety.
Process of IRB Continuing Review
The process of IRB continuing review typically involves the submission of a continuing review application by the study's principal investigator. The application must include updated information about the study's progress, any changes to the protocol, and any adverse events or unanticipated problems that have occurred.
The IRB reviews the application and may request additional information or clarification before making a decision. The IRB may also conduct a full board review or a expedited review, depending on the study's risk level and the nature of the changes proposed.
Regulatory Requirements for IRB Continuing Review
The regulatory requirements for IRB continuing review are outlined in the federal regulations, including 45 CFR 46 and 21 CFR 50 and 56. These regulations require that IRBs review research studies at intervals appropriate to the degree of risk, but not less than once per year.
The regulations also require that the IRB review any changes to the study protocol, including changes to the informed consent document, to ensure that they are consistent with the original approval. The IRB must also ensure that the study is being conducted in accordance with the approved protocol and that the rights and welfare of the participants are protected.
Best Practices for IRB Continuing Review
To ensure a smooth and efficient IRB continuing review process, it is essential to maintain accurate and up-to-date records of the study's progress, including any changes to the protocol and any adverse events or unanticipated problems that have occurred.
It is also essential to communicate effectively with the IRB and to respond promptly to any requests for additional information or clarification. By following these best practices, researchers can ensure that their studies are conducted in compliance with the regulatory requirements and that the rights and welfare of the participants are protected.
Frequently Asked Questions
What is the purpose of IRB continuing review?
The purpose of IRB continuing review is to ensure that the study is being conducted in accordance with the approved protocol and that the rights and welfare of the participants are protected.
How often is IRB continuing review required?
IRB continuing review is required at intervals appropriate to the degree of risk, but not less than once per year.
What information is required for IRB continuing review?
The information required for IRB continuing review includes updated information about the study's progress, any changes to the protocol, and any adverse events or unanticipated problems that have occurred.
Who is responsible for submitting the IRB continuing review application?
The principal investigator is responsible for submitting the IRB continuing review application.
What happens if the IRB requires changes to the study protocol?
If the IRB requires changes to the study protocol, the researcher must implement the changes and submit a revised protocol for IRB approval.
Can the IRB terminate a study during the continuing review process?
Yes, the IRB can terminate a study during the continuing review process if it determines that the study is not being conducted in accordance with the approved protocol or that the risks to participants outweigh the benefits.